Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program and translational research in aerodigestive cancers, outlined in an interview ...

Medically reviewed by Doru Paul, MD Key Takeaways Survival rates for stage 3 lung cancer can vary between 13% to 36% depending on the subtype.Stage 3a lung cancer is often treated with surgery and ...

Lung cancer is the leading cause of cancer-related mortality worldwide, with significant heterogeneity among its major histological subtypes: adenocarcinoma (ADC), squamous cell carcinoma (SCC), and ...

Both non-small lung cancer and small cell lung cancer is a disease that now has various therapeutic options available, according to experts. Lung cancer is a disease that now has various therapeutic ...

Fine particulate matter PM2.5 increases the risk of all subtypes of lung cancer, while NO2, O3 and SO2 are linked to non-small-cell lung cancer “We used national air quality data combined with ...

A model composed of perfluorooctanesulfonic acid (PFOS), perfluoroheptanoic acid (PFHA), and the plasticizer ...

Using the OncoArray genotyping platform developed by multiple cancer consortia, a recent large aggregated genomewide association study identifies new susceptibility loci for lung cancer, the leading ...

A newly released publication examines how deuterium concentration may influence gene activity in lung cancer cells. The study explores how shifts in this ...

HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...